Tremfya (guselkumab) - J&J
Tremfya: Regulatory approval in US/EU for psoriatic arthritis in 2020 (J&J) - Apr 14, 2020 - Key 2020 Events 
European regulatory • sBLA Immunology • Psoriasis
http://www.investor.jnj.com/pharmaceutical-pipeline/key-events-2020
 
Apr 14, 2020
 
 
0be6528d-c985-4634-9743-0fd5a21fa542.jpg